Headline
The latest stories from AHA Today.
The AHA today commented to House and Senate appropriations committee leaders on funding for health care programs in the fiscal year 2026 appropriations bill.
Coalition ad links decisions on Medicaid cuts by Congress to impacts on hospitals
AHA podcast: Food as Medicine — How Cleveland Clinic Is Nourishing Community Health
The latest video in the AHA’s series “Medicaid: Real Lives, Real Care” features Becky Pletzer, a licensed clinical social worker from Alaska, explaining why it is important to protect Medicaid for children who rely on it, such as her son, and why her story could apply to anyone.
More than 250 hospital and health system leaders today participated in an AHA Advocacy Day briefing in Washington, D.C.
A report released June 17 by NORC at the University of Chicago, commissioned by the Coalition to Strengthen America’s Healthcare, found that patients enrolled in Medicare Advantage plans are more likely to experience longer hospital stays and experience delays in transfer to post-acute care…
The Senate Finance Committee June 16 released its draft legislative text as part of the Senate’s version of the budget reconciliation bill. The committee, which has jurisdiction over Medicaid and taxes, has discussed additional restrictions on state-directed payments and provider taxes, as compared…
Wrenetha Julion, Ph.D., R.N., of Rush University Medical Center, and Paul Florsheim, Ph.D., of the University of Wisconsin-Milwaukee, discuss the collaborative Preparing for Parenthood program, success stories on how to engage fathers early in the pregnancy journey, and what supporting dads mean…
The Centers for Medicare & Medicaid Services June 13 announced it approved state plan amendments to expand Medicaid access to care for tribal communities in six states: Minnesota, New Mexico, Oregon, South Dakota, Washington and Wyoming
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater oversight by the federal government, but they also significantly outperform drug companies in terms of program compliance.